Guidelines International Network | Guidelines International Network (GIN)

Riech- und Schmeckstörungen. S2k-LL (DGHNO-KHC)

MeSH Terms: Smell (F02.830.816.643); Smell (G11.561.600.810.643); Taste Disorders (C10.597.751.861); Taste Disorders (C23.888.592.763.861)
Guideline Contact: Ina Kopp (imwi@awmf.org)
English Title Translation: Smell and taste disorders
Keywords: Riechstörungen, Schmeckstörungen, Riechvermögen, Dysosmie, Riechfunktion, Dysgeusie, Schmeckvermögen
Date for Review: 30/04/2028
Publication Date: 07/08/2023
Publication Scope: management
Countries of Application: Germany
Guideline Publication Status: Published
Languages: German
Authors: AWMF (DE)
Publication Year: 2023

MeSH Terms: Bandages (E07.101); Beds (E07.325.220); Pressure Ulcer (C17.800.893.665); Risk Assessment (E05.318.740.600.800.715); Enteral Nutrition (E02.642.500.360); Skin Cream (E02.547.800.500)
Guideline Contact: Amir Qaseem (aqaseem@acponline.org)
Publication Scope: assessment; prevention
Countries of Application: United States
Guideline Publication Status: Published
Languages: English
Authors: ACP (US)
Publication Year: 2015

MeSH Terms: Delirium (F03.087.350); Inpatients (M01.643.470); Risk Factors (E05.318.740.600.800.725)
Publication Scope: assessment
Countries of Application: Australia
Guideline Publication Status: Published
Languages: English
Authors: JBI (AU)
Publication Year: 2013

MeSH Terms: Meta-Analysis as Topic (E05.581.500.501); Meta-Analysis (V03.600); Randomized Controlled Trial (V03.200.700); Practice Guideline (V02.515.500)
Guideline Contact: Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2015

MeSH Terms: pancreatic neoplasms, carcinoma, pancreatic ductal, pancreatic ductal adenocarcinoma, pancreatic cancer, pancreas cancer, pancreas adenocarcinoma, adjuvant treatment, cancer adjuvant therapy, adjuvant therapy, resected pancreatic ductal adenocarcinoma, chemotherapy, adjuvant, antineoplastic agents, drug therapy, pancreas adenocarcinoma, pancreas carcinoma, pancreas tumor, adjuvant chemotherapy, adjuvant chemoradiotherapy
Guideline Contact: Roxanne Cosby; pebconc@mcmaster.ca
Keywords: pancreatic ductal adenocarcinoma, pancreatic cancer, adjuvant treatment, antineoplastic agents, adjuvant chemoradiotherapy
Date for Review: In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Publication Date: 2022-06-20
Date of Last Evidence Search: 2021-11-25
Methods Applied: Systematic review-based, Externally reviewed, Evidence quality assessment, Patient/survivors/caregivers participation
Publication Scope: Guidelines; treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: PEBC (Program in evidenced-based care)
Publication Year: 2022